In Response to: Corticosteroids in Non-severe COVID-19: Finding Window of Opportunity
Citation Information :
In Response to: Corticosteroids in Non-severe COVID-19: Finding Window of Opportunity. Indian J Crit Care Med 2022; 26 (3):405-405.
Nasa P, Chaudhry D, Govil D, Daga MK, Jain R, Chhallani AA, et al. Expert consensus statements on the use of corticosteroids in non-severe COVID-19. Indian J Crit Care Med 2021;25(11):1280–1285. DOI: 10.5005/jp-journals-10071-23923.
Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med 2021;27(1):28–33. DOI: 10.1038/s41591-020-01202-8.
Agarwal A, Rochwerg B, Lamontagne F, Siemieniuk RA, Agoritsas T, Askie L, et al. A living WHO guideline on drugs for covid-19. British Medical Journal 2020;370:m3379. DOI: 10.1136/bmj.m3379.
Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. Dexamethasone in hospitalized patients with covid-19. N Engl J Med 2021;384:693–704. DOI: 10.1056/NEJMoa2021436.
Nasa P, Jain R, Juneja D. Delphi methodology in healthcare research: how to decide its appropriateness. World J Methodol 2021;11(4): 116–129. DOI: 10.5662/wjm.v11.i4.116.
Li J, He X, Yuan Y, Zhang W, Li X, Zhang Y, et al. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia. Am J Infect Control 2021;49(1):82–89. DOI: 10.1016/j.ajic.2020.06.008.
Ishfaq A, Yousaf Farooq SM, Goraya A, Yousaf M, Gilani SA, Kiran A, et al. Role of high resolution computed tomography chest in the diagnosis and evaluation of COVID-19 patients: a systematic review and meta-analysis. Eur J Radiol Open 2021;8:100350. DOI: 10.1016/j.ejro.2021.100350.
Bhattacharyya A, Sarma P, Kaur H, Kumar S, Bhattacharyya J, Prajapat M, et al. COVID-19-associated rhino-orbital-cerebral mucormycosis: a systematic review, meta-analysis, and meta-regression analysis. Indian J Pharmacol 2021;53(6):499–510. DOI: 10.4103/ijp.ijp_839_21.
